Intracellular Th
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $199,223 | $175,159 | $161,388 | $144,866 |
Gross Profit | 178,818 | 159,855 | 150,034 | 134,966 |
EBITDA | -29,088 | -38,849 | -27,594 | -20,820 |
EBIT | -29,197 | -38,987 | -27,723 | -20,952 |
Net Income | -16,885 | -26,324 | -16,219 | -15,247 |
Net Change In Cash | 199,223 | 175,159 | 161,388 | 144,866 |
Free Cash Flow | -12,651 | -27,221 | 489 | -34,116 |
Cash | 306,948 | 464,312 | 695,056 | 141,569 |
Basic Shares | 103,131 | 105,768 | 103,723 | 96,875 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $680,852 | $464,370 | $249,132 | $81,707 |
Gross Profit | 623,889 | 430,625 | 228,689 | 73,673 |
EBITDA | -116,721 | -158,853 | -262,970 | -285,154 |
EBIT | -159,381 | -263,626 | -285,688 | |
Net Income | -74,676 | -139,674 | -256,256 | -284,125 |
Net Change In Cash | 680,852 | 464,370 | 249,132 | 81,707 |
Cost of Revenue | 56,600 | 32,319 | ||
Free Cash Flow | -73,499 | -124,468 | -270,964 | -259,869 |
Cash | 306,948 | 147,767 | 148,615 | 92,364 |
Basic Shares | 103,131 | 95,881 | 94,046 | 81,253 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.16 |
2024-09-30 | -$0.25 |
2024-06-30 | -$0.16 |
2024-03-31 | -$0.16 |
